ASSESSMENT OF USEFULNESS OF NEXT GENERATION SEQUENCING IN CANCER IDENTIFICATION AND TREATMENT

NOTICE PAPER NO. 3318

NOTICE OF QUESTION FOR WRITTEN ANSWER

FOR THE SITTING OF PARLIMENT ON OR AFTER 8 JANUARY 2025

Name and Constituency of Member of Parliament

Mr Chua Kheng Wee Louis,

MP for Sengkang GRC

Question No. 6417

To ask the Minister for Health (a) what is the prevalence of next generation sequencing (NGS), a technology for determining the sequence of DNA or RNA to study genetic variation associated with diseases or other biological phenomena, in Singapore; (b) what is the Government’s assessment of the usefulness of NGS in cancer identification and treatment; and (c) whether the Government intends to provide guidelines on the use of NGS in Singapore.

Answer

This question has been addressed in written reply to Parliamentary Question No 35 on 7 January 2025 sitting.